Why Did Hemispherx Crash Yesterday?

Hemispherx Biopharma (HEB – $0.32) lost more than 38% of its market value yesterady because it announced that its PDUFA date would be extended by three months. A small recap. In July of 2008 the U.S. Food and Drug Administration (FDA) accepted for review the Company’s New Drug Application (NDA) for Ampligen to treat Chronic Fatigue Syndrome (CFS). Hemispherx is […]

Read more

Boots & Coots – Initial Interview

Our guest today is Mr. Jerry Winchester, President and CEO of Boots & Coots International Well Control Inc. (Alternext US: WEL). Boots & Coots International Well Control, Inc. provides a suite of integrated pressure control services to onshore and offshore oil and gas exploration companies around the world. The Company operates in two business segments: Well Intervention and Response. The […]

Read more

Global Green Solutions – Initial Interview

Our guest today is Mr. Doug Frater, President and Chief Executive Officer of Global Green Solutions Inc. (OTCBB: GGRN). Global Green Solutions Inc. is rapidly becoming a worldwide leader in the development of alternative energy resources and greenhouse gas reduction technology. With an expanding portfolio of ecotechnology-based products and services, Global Green Solutions is tackling the challenge of global warming […]

Read more
1 6 7 8